Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
Altis Labs has unveiled Nota, a groundbreaking clinical information platform designed to expedite therapeutic research and development. By harnessing the power of AI, Nota can forecast patient outcomes based on imaging data, allowing sponsors to efficiently prioritize their most promising therapies. This innovative platform empowers researchers to effectively utilize clinical trial imaging data, gain access to predictive imaging biomarkers, and enhance R&D efforts on a larger scale. With Altis’ cloud-based software, which employs advanced deep learning techniques, biopharma companies can integrate detailed outcome predictions at the image, patient, and cohort levels, ultimately refining clinical trial design and boosting confidence in anticipating clinical endpoints. The insights generated by Nota have the potential to drastically shorten development timelines, reduce drug development expenses, and increase the chances of success across various therapeutic areas, paving the way for a new era in clinical research. As the demand for efficient drug development continues to rise, Nota stands out as a vital tool for the biopharmaceutical industry.
Description
Optimized AI is set to roll out its on-device capabilities, facilitating the deployment of AI models directly onto physical devices. By utilizing LaunchX automation, users can streamline the conversion process and easily assess performance metrics on designated devices. The platform can be tailored to align with specific hardware requirements, ensuring a seamless integration of AI models within a customized software ecosystem. Nota's AI innovations are designed to enhance intelligent transportation systems, facial recognition technology, and security surveillance mechanisms. Among their offerings are a driver monitoring system, robust driver authentication solutions, and smart access control systems. Nota is actively engaged in diverse sectors, such as construction, mobility, security, smart home technology, and healthcare. Furthermore, partnerships with leading global firms like Nvidia, Intel, and ARM have significantly boosted Nota's ability to penetrate the international market. The company is committed to pushing the boundaries of AI applications across various industries to create smarter environments.
API Access
Has API
No
API Access
Has API
No
Integrations
Arm MAP
No
NVIDIA AI Enterprise
No
NVIDIA TensorRT
No
NetsPresso
No
ONNX
No
OpenVINO
No
Raspberry Pi OS
No
TensorFlow
No
Integrations
Arm MAP
Yes
NVIDIA AI Enterprise
Yes
NVIDIA TensorRT
Yes
NetsPresso
Yes
ONNX
Yes
OpenVINO
Yes
Raspberry Pi OS
Yes
TensorFlow
Yes
Pricing Details
No price information available.
Free Trial
No
Free Version
No
Pricing Details
No price information available.
Free Trial
No
Free Version
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Customer Support
Business Hours
No
Live Rep (24/7)
No
Online Support
Yes
Customer Support
Business Hours
Yes
Live Rep (24/7)
No
Online Support
Yes
Types of Training
Training Docs
No
Webinars
No
Live Training (Online)
No
In Person
No
Types of Training
Training Docs
Yes
Webinars
No
Live Training (Online)
No
In Person
No
Vendor Details
Company Name
Altis Labs
Founded
2019
Country
Canada
Website
www.altislabs.com/news/altis-labs-announces-launch-of-nota-a-clinical-information-platform-to-accelerate-therapeutic-r-d
Vendor Details
Company Name
Nota AI
Founded
2015
Country
South Korea
Website
www.nota.ai/launchx